Show simple item record

dc.contributor.authorRescigno, P
dc.contributor.authorRodrigues, DN
dc.contributor.authorde Bono, JS
dc.date.accessioned2017-01-18T15:35:18Z
dc.date.issued2017-01-01
dc.identifier.citationBJU international, 2017, 119 (1), pp. 3 - 4
dc.identifier.issn1464-4096
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/392
dc.identifier.eissn1464-410X
dc.identifier.doi10.1111/bju.13550
dc.formatPrint
dc.format.extent3 - 4
dc.languageeng
dc.language.isoeng
dc.publisherWILEY-BLACKWELL
dc.subjectHumans
dc.subjectProstatic Neoplasms
dc.subjectMale
dc.subjectBiomarkers
dc.subjectBiomarkers, Tumor
dc.titleCirculating biomarkers of neuroendocrine prostate cancer: an unmet challenge.
dc.typeJournal Article
rioxxterms.versionofrecord10.1111/bju.13550
rioxxterms.licenseref.startdate2017-01
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfBJU international
pubs.issue1
pubs.notesNo embargo
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Prostate Cancer Targeted Therapy Group
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Prostate Cancer Targeted Therapy Group
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.publication-statusPublished
pubs.volume119
pubs.embargo.termsNo embargo
icr.researchteamProstate Cancer Targeted Therapy Group
dc.contributor.icrauthorRescigno, Pasquale
dc.contributor.icrauthorDe Bono, Johann


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record